Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma × CP protocol × Clear all

Phase

Status

Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Unresectable Stage III NSCLC 1 Squamous Cell Carcinoma of Head and Neck 1 Ovarian Neoplasms 1 Neoplasms, Unknown Primary 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma 1 Breast Neoplasms 1

Interventions

pembrolizumab 3 anlotinib 3 Paclitaxel 3 Cetuximab 3 sintilimab 2 Sorafenib 2 Radiotherapy 2 Leucovorin 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cisplatin 2 vistusertib 1 titanium silicide 1 tislelizumab 1 tirbanibulin 1 surufatinib 1 regorafenib 1 poly ICLC 1 pemigatinib 1 olaparib 1 durvalumab 1 donafenib 1 daromun 1 avelumab 1 atezolizumab 1 advexin 1 Therapeutics 1 Temozolomide 1 Sunitinib 1 SYN-004 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00894569 2009-05-14

PACET-CUP

Heidelberg University

Phase 2 Unknown

Carcinoma, Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡